✦ LIBER ✦

Exploring Breast Cancer Therapies: Comparing Aromatase Inhibitors to Current Therapies

✍ Scribed by Alteneder, Ruth R.

Book ID: 109266511
Publisher: John Wiley and Sons
Year: 2005
Weight: 200 KB
Volume: 9
Category: Article
ISSN: 1091-5923
DOI: 10.1111/j.1552-6356.2005.tb00748.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current concepts in the endocrine therap

Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors

✍ G. Sing Ranger 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Aromatase inhibitors: past, present and

Aromatase inhibitors: past, present and future in breast cancer therapy

✍ Udayan Dutta; Kartikeya Pant 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 254 KB

The use of aromatase inhibitors in adjuv

The use of aromatase inhibitors in adjuvant therapy for early breast cancer

✍ Walter Jonat; Felix Hilpert; Nicolai Maass 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 250 KB

Identifying breast cancer patients most

Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen

✍ Christopher M. Booth; Joseph L. Pater; Paul E. Goss 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

Identifying Breast Cancer Patients Most Likely to Benefit From Aromatase Inhibitor Therapy After Adjuvant Tamoxifen W e are responding to the recently published study by Freedman and colleagues in which it is suggested that the benefits of adding an aromatase inhibitor after 5 years of adjuvant tamo

Identifying breast cancer patients most

Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen

✍ Gary M. Freedman; Penny Anderson; Tianyu Li; Eric Ross; Ramona Swaby; Lori Golds 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

Adjuvant aromatase inhibitor therapy for

Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data

✍ G. Grana 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract Tamoxifen is the established adjuvant treatment for postmenopausal women with hormone‐sensitive early breast cancer. However, the side‐effects associated with tamoxifen therapy have prompted a search for safer and potentially more effective endocrine agents. Results from randomized tria